Guangan He

1.1k total citations
26 papers, 846 citations indexed

About

Guangan He is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Guangan He has authored 26 papers receiving a total of 846 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 13 papers in Oncology and 5 papers in Cancer Research. Recurrent topics in Guangan He's work include DNA Repair Mechanisms (8 papers), Cancer-related Molecular Pathways (7 papers) and Metal complexes synthesis and properties (5 papers). Guangan He is often cited by papers focused on DNA Repair Mechanisms (8 papers), Cancer-related Molecular Pathways (7 papers) and Metal complexes synthesis and properties (5 papers). Guangan He collaborates with scholars based in United States, Mexico and Canada. Guangan He's co-authors include Zahid H. Siddik, Jian Kuang, Ruoning Wang, Abdul R. Khokhar, John M. Koomen, Ryûji Kobayashi, Gary E. Gallick, Mayra Nelman‐Gonzalez, Grégory Thiabaud and Jonathan F. Arambula and has published in prestigious journals such as Cell, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Guangan He

25 papers receiving 831 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Guangan He United States 14 507 319 139 119 77 26 846
Olivier Reelfs United Kingdom 15 594 1.2× 373 1.2× 68 0.5× 139 1.2× 131 1.7× 20 977
Benny Zhitomirsky Israel 7 491 1.0× 200 0.6× 97 0.7× 111 0.9× 66 0.9× 7 860
Hongliang Zong China 20 708 1.4× 259 0.8× 89 0.6× 118 1.0× 139 1.8× 34 1.1k
Kumaresan Ganesan India 16 574 1.1× 239 0.7× 82 0.6× 224 1.9× 132 1.7× 45 967
Michal Stark Israel 18 627 1.2× 279 0.9× 63 0.5× 147 1.2× 84 1.1× 31 1.1k
Qian Guo China 14 710 1.4× 122 0.4× 100 0.7× 140 1.2× 67 0.9× 43 994
Ganesh Nagaraju India 22 1.1k 2.2× 459 1.4× 64 0.5× 206 1.7× 92 1.2× 36 1.5k
Amelia L. Parker Australia 12 441 0.9× 222 0.7× 239 1.7× 117 1.0× 112 1.5× 16 815
Alakesh Das India 15 392 0.8× 342 1.1× 226 1.6× 178 1.5× 75 1.0× 33 972
Elizabeth Alli United States 12 483 1.0× 406 1.3× 191 1.4× 194 1.6× 98 1.3× 19 819

Countries citing papers authored by Guangan He

Since Specialization
Citations

This map shows the geographic impact of Guangan He's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guangan He with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guangan He more than expected).

Fields of papers citing papers by Guangan He

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Guangan He. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guangan He. The network helps show where Guangan He may publish in the future.

Co-authorship network of co-authors of Guangan He

This figure shows the co-authorship network connecting the top 25 collaborators of Guangan He. A scholar is included among the top collaborators of Guangan He based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Guangan He. Guangan He is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
He, Guangan, Grégory Thiabaud, Jonathan L. Sessler, et al.. (2021). Abstract 1073: Preclinical tissue biodistribution and plasma pharmacokinetic studies with oxaliTEX, a novel platinum(IV)-based oxaliplatin prodrug. Cancer Research. 81(13_Supplement). 1073–1073. 1 indexed citations
2.
Hong, Bangxing, Uksha Saini, David E. Cohn, et al.. (2020). Oncolytic HSV Therapy Modulates Vesicular Trafficking Inducing Cisplatin Sensitivity and Antitumor Immunity. Clinical Cancer Research. 27(2). 542–553. 23 indexed citations
3.
He, Guangan, Xiaolei Xie, & Zahid H. Siddik. (2020). Protein expression profiling identifies differential modulation of homologous recombination by platinum-based antitumor agents. Cancer Chemotherapy and Pharmacology. 85(6). 1129–1140. 2 indexed citations
4.
Thiabaud, Grégory, Guangan He, Sajal Sen, et al.. (2020). Oxaliplatin Pt(IV) prodrugs conjugated to gadolinium-texaphyrin as potential antitumor agents. Proceedings of the National Academy of Sciences. 117(13). 7021–7029. 49 indexed citations
5.
Xie, Xiaolei, Guangan He, & Zahid H. Siddik. (2020). Cisplatin in Combination with MDM2 Inhibition Downregulates Rad51 Recombinase in a Bimodal Manner to Inhibit Homologous Recombination and Augment Tumor Cell Kill. Molecular Pharmacology. 97(4). 237–249. 7 indexed citations
6.
Rodriguez‐Aguayo, Cristian, Emine Bayraktar, Cristina Ivan, et al.. (2019). PTGER3 induces ovary tumorigenesis and confers resistance to cisplatin therapy through up-regulation Ras-MAPK/Erk-ETS1-ELK1/CFTR1 axis. EBioMedicine. 40. 290–304. 37 indexed citations
7.
Rodriguez‐Aguayo, Cristian, Emine Bayraktar, Cristina Ivan, et al.. (2018). PTGER3 Induces Ovary Tumorigenesis and Confers Resistance to Cisplatin Therapy Through Up-Regulation Ras-MAPK/Erk-ETS1-ELK1/CFTR1 Axis. SSRN Electronic Journal. 3 indexed citations
8.
Thiabaud, Grégory, et al.. (2016). Activation of Platinum(IV) Prodrugs By Motexafin Gadolinium as a Redox Mediator. Angewandte Chemie. 128(41). 12816–12821. 14 indexed citations
9.
Thiabaud, Grégory, et al.. (2016). Activation of Platinum(IV) Prodrugs By Motexafin Gadolinium as a Redox Mediator. Angewandte Chemie International Edition. 55(41). 12626–12631. 65 indexed citations
10.
Tsimberidou, Apostolia M., Rabih Said, Kirk S. Culotta, et al.. (2015). Phase I study of azacitidine and oxaliplatin in patients with advanced cancers that have relapsed or are refractory to any platinum therapy. Clinical Epigenetics. 7(1). 29–29. 14 indexed citations
11.
Kim, Eric S., J. Jack Lee, Guangan He, et al.. (2012). Tissue Platinum Concentration and Tumor Response in Non–Small-Cell Lung Cancer. Journal of Clinical Oncology. 30(27). 3345–3352. 81 indexed citations
12.
He, Guangan, Jian Kuang, Abdul R. Khokhar, & Zahid H. Siddik. (2011). The impact of S- and G2-checkpoint response on the fidelity of G1-arrest by cisplatin and its comparison to a non-cross-resistant platinum(IV) analog. Gynecologic Oncology. 122(2). 402–409. 40 indexed citations
13.
Le, Xiao-Feng, Weiqun Mao, Guangan He, et al.. (2011). The Role of p27 Kip1 in Dasatinib-Enhanced Paclitaxel Cytotoxicity in Human Ovarian Cancer Cells. JNCI Journal of the National Cancer Institute. 103(18). 1403–1422. 23 indexed citations
14.
Rowe, R. W., F. R. Strebel, Wanleng Deng, et al.. (2010). Fever-range whole body thermotherapy combined with oxaliplatin: A curative regimen in a pre-clinical breast cancer model. International Journal of Hyperthermia. 26(6). 565–576. 14 indexed citations
15.
Kurokawa, Tetsuji, Guangan He, & Zahid H. Siddik. (2009). Protein kinase inhibitors emodin and dichloro-ribofuranosylbenzimidazole modulate the cellular accumulation and cytotoxicity of cisplatin in a schedule-dependent manner. Cancer Chemotherapy and Pharmacology. 65(3). 427–436. 10 indexed citations
16.
Wang, Ruoning, Guangan He, Mayra Nelman‐Gonzalez, et al.. (2007). Regulation of Cdc25C by ERK-MAP Kinases during the G2/M Transition. Cell. 128(6). 1119–1132. 109 indexed citations
17.
Pan, Shujuan, Ruoning Wang, Xi Zhou, et al.. (2006). Involvement of the Conserved Adaptor Protein Alix in Actin Cytoskeleton Assembly. Journal of Biological Chemistry. 281(45). 34640–34650. 55 indexed citations
18.
He, Guangan, Zahid H. Siddik, Ruoning Wang, et al.. (2005). Induction of p21 by p53 following DNA damage inhibits both Cdk4 and Cdk2 activities. Oncogene. 24(18). 2929–2943. 219 indexed citations
19.
He, Guangan, Huimin Hou, & Xiaojun Liu. (2001). Naltrexone microspheres: in vitro release and effect on morphine analgesia in mice.. PubMed. 22(6). 530–3. 8 indexed citations
20.
Wu, Ying, Shujuan Pan, Shaoli Che, et al.. (2001). Overexpression of Hp95 induces G1 phase arrest in confluent HeLa cells. Differentiation. 67(4-5). 139–153. 39 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Olivier Reelfs Breakdown of academic impact, for papers by Benny Zhitomirsky Breakdown of academic impact, for papers by Hongliang Zong Breakdown of academic impact, for papers by Kumaresan Ganesan Breakdown of academic impact, for papers by Michal Stark Breakdown of academic impact, for papers by Qian Guo Breakdown of academic impact, for papers by Ganesh Nagaraju Breakdown of academic impact, for papers by Amelia L. Parker Breakdown of academic impact, for papers by Alakesh Das Breakdown of academic impact, for papers by Elizabeth Alli
Rankless by CCL
2026